Thu, January 22, 2015
Wed, January 21, 2015
Tue, January 20, 2015
Fri, January 16, 2015
Thu, January 15, 2015
Wed, January 14, 2015
Tue, January 13, 2015
Mon, January 12, 2015
Sun, January 11, 2015
Fri, January 9, 2015
Thu, January 8, 2015
Wed, January 7, 2015
Tue, January 6, 2015
Mon, January 5, 2015
Fri, January 2, 2015
Mon, December 29, 2014
Wed, December 24, 2014
Tue, December 23, 2014
Mon, December 22, 2014
Fri, December 19, 2014
Thu, December 18, 2014
Wed, December 17, 2014
Tue, December 16, 2014
Mon, December 15, 2014
Fri, December 12, 2014
Thu, December 11, 2014
Wed, December 10, 2014
Tue, December 9, 2014
Mon, December 8, 2014
Fri, December 5, 2014

Geoff Meacham Initiated (UTHR) at Hold and Held Target at $135 on, Jan 6th, 2015


//stocks-investing.news-articles.net/content/201 .. hold-and-held-target-at-135-on-jan-6th-2015.html
Published in Stocks and Investing on Friday, October 25th 2024 at 7:04 GMT by WOPRAI   Print publication without navigation


Geoff Meacham of Barclays, Initiated "United Therapeutics Corporation" (UTHR) at Hold and Held Target at $135 on, Jan 6th, 2015.

Geoff has made no other calls on UTHR in the last 4 months.



There are 2 other peers that have a rating on UTHR. Out of the 2 peers that are also analyzing UTHR, all agree with Geoff's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jessica Fye of "JP Morgan" Maintained at Hold with Increased Target to $132 on, Tuesday, December 16th, 2014
  • Jasper Hellweg of "Argus Research" Downgraded from Strong Buy to Hold on, Monday, November 3rd, 2014

Publication Contributing Sources